| Application no. and date | 18741607.8 (espacenet) (Federated) (European Patent Register), 20180118 | | Patent/reg. no. and date | DK/EP 3570940, 20231213 | | Publication date | 20191127 | | Priority no. and date | US 201762448595 P, 20170120 | | EP pub. no. and date |
EP 3570940 20191127 | | Effective date | | | Applicant/owner | National University of Singapore, 21 Lower Kent Ridge Road
Singapore 119077, SG,
Agency for Science, Technology and Research, 1 Fusionopolis Way
20-10 Connexis North
Singapore 138632, SG,
Prilenia Neurotherapeutics Ltd., 10 HaMenofim Street
4672561 Herzliya, IL | | Applicant ref. no. | 20026, 20027 | | Inventor | HAYDEN, Michael, c/o 5 Basel Street
P.O. Box 3190
49131 Petach-Tikva, IL,
POULADI, Mahmoud, Abdulhossein, 105 Clementi Road
Block B 04-02
Singapore 129789, SG | | Representative | COSMOVICI INTELLECTUAL PROPERTY, Rue de la Corraterie 5
1204 Geneva, CH | | Opponent | | | IPC Class | A61K 31/451 (2006.01) , A61K 45/06 (2006.01) , A61P 25/28 (2006.01) | | Title | PRIDOPIDIN TIL ANVENDELSE I BEHANDLING AF FRAGILT X-SYNDROM | | Int. application no. | US2018014169 | | Int. publication no. | WO2018136600 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
